Diclazepam
Diclazepam (also known as Chlorodiazepam and 2'-chloro-diazepam) is a benzodiazepine derivative first synthesized in 1960 by Leo Sternbach and his team at Hoffmann-La Roche. It is a psychoactive drug with anxiolytic, sedative, muscle relaxant, and amnesic properties.
Chemistry[edit]
Diclazepam is a 2'-chloro derivative of diazepam, and is also a member of the benzodiazepine class. It is structurally related to diazepam in that the benzene ring has been replaced by a thiophene ring.
Pharmacology[edit]
Diclazepam has a similar range of effects to other benzodiazepines, including anxiolytic, hypnotic, sedative, amnesic, and muscle relaxant effects. However, it is notably stronger, with a 10 times higher potency than diazepam. It works by binding to the GABA receptor, increasing the efficiency of the neurotransmitter.
Medical Use[edit]
While Diclazepam is not currently approved for medical use in many countries, it is used in some countries as a more potent substitute for diazepam in the treatment of anxiety, insomnia, and seizures. It is also used in the treatment of alcohol withdrawal.
Recreational Use[edit]
Diclazepam is also used recreationally for its sedative and anxiety-reducing effects. However, it is a controlled substance in many countries due to its potential for abuse and addiction.
Legal Status[edit]
The legal status of Diclazepam varies by country. In the United States, it is classified as a Schedule IV controlled substance. In the United Kingdom, it is a Class C drug.
See Also[edit]
References[edit]
This benzodiazepine-related article is a stub. You can help WikiMD by expanding it.
